You’re doing a Q-bank block, you see an adnexal mass, and suddenly every ovarian tumor you’ve ever learned shows up in your head at once: cystadenocarcinoma, dysgerminoma, granulosa cell tumor, theca cell tumor, Sertoli-Leydig… The trick isn’t memorizing a list—it’s learning to extract the tumor type from the vignette and then weaponize the distractors. This post walks through a classic USMLE-style case and then breaks down why each answer choice is wrong (or less right), with high-yield pearls you can reuse immediately.
The Clinical Vignette (Q-bank style)
A 63-year-old postmenopausal woman presents with 3 months of progressive abdominal bloating and early satiety. She has lost 4.5 kg (10 lb) without trying. Exam shows a distended abdomen with shifting dullness and a firm left adnexal mass. Ultrasound reveals a complex ovarian mass with solid components and papillary projections. Serum CA-125 is elevated. Paracentesis demonstrates malignant cells.
Which tumor is the most likely diagnosis?
A. Dysgerminoma
B. Granulosa cell tumor
C. High-grade serous carcinoma
D. Mature cystic teratoma (dermoid cyst)
E. Sertoli-Leydig cell tumor
Step-by-Step: Why the Correct Answer Wins
✅ Correct Answer: C. High-grade serous carcinoma
This is the prototypical surface epithelial ovarian cancer presentation:
Clues in the stem
- Postmenopausal age (surface epithelial tumors are most common overall, especially in older patients)
- Bloating + early satiety + weight loss → ovarian cancer often presents late with nonspecific GI complaints
- Ascites and malignant cells in peritoneal fluid → peritoneal spread
- Complex mass with solid areas + papillary projections → classic for epithelial malignancy
- Elevated CA-125 → associated marker (not a screening test)
High-yield pathology
- High-grade serous carcinoma is the most common malignant ovarian tumor
- Often associated with TP53 mutations
- Many arise from serous tubal intraepithelial carcinoma (STIC) in the fimbriae (important modern concept)
Classic gross/clinical
- Bilateral ovarian masses can occur
- Peritoneal seeding → omental caking, ascites
- Presents late → worse prognosis compared to endometrial cancer
Distractor Autopsy: Why Each Wrong Answer Is Tempting (and Why It’s Wrong)
A. Dysgerminoma (Germ cell tumor)
Why it tempts you: It’s a famous ovarian tumor and shows up often on Step.
Why it’s wrong here
- Age mismatch: Dysgerminomas are classically in teens/young women (2nd–3rd decade)
- Tumor markers: often ↑ LDH, sometimes β-hCG (if syncytiotrophoblasts present)
- Not the typical CA-125/ascites/papillary projection story
High-yield dysgerminoma facts
- Ovarian counterpart of seminoma
- Large, solid mass
- Sheets of uniform cells with clear cytoplasm + fibrous septa with lymphocytes
- Highly radiosensitive and relatively good prognosis
B. Granulosa cell tumor (Sex cord-stromal)
Why it tempts you: Postmenopausal + ovarian tumor is a common setup.
Why it’s wrong here
- Granulosa cell tumors are defined by estrogen production
- The vignette doesn’t give estrogen effects:
- Postmenopausal bleeding
- Endometrial hyperplasia/carcinoma risk
- Breast tenderness, increased endometrial stripe
What you’d expect instead
- Abnormal uterine bleeding is a huge clue
- Possible precocious puberty in children (rare but classic board fact)
- Marker: inhibin (especially inhibin B)
Histology buzzwords
- Call-Exner bodies (small follicles with eosinophilic fluid)
- “Coffee-bean” nuclei (nuclear grooves)
D. Mature cystic teratoma (Dermoid cyst) (Germ cell tumor)
Why it tempts you: It’s the most common benign ovarian tumor and a common distractor.
Why it’s wrong here
- Age: typically reproductive-age women, not classically 63
- Usually benign and doesn’t present with malignant ascites/cytology
- Imaging often shows:
- Cystic lesion with calcifications, fat-fluid levels
- Symptoms: often asymptomatic or torsion
High-yield dermoid facts
- Derived from totipotent germ cells
- Contains tissues from all 3 germ layers (hair/teeth are classic)
- Complication: ovarian torsion
- Rare malignant transformation (e.g., squamous cell carcinoma) but that’s not the standard USMLE framing unless explicitly signaled
E. Sertoli-Leydig cell tumor (Sex cord-stromal)
Why it tempts you: Another classic ovarian tumor category that students mix up with granulosa/thecoma.
Why it’s wrong here
- Sertoli-Leydig tumors produce androgens
- You’d expect virilization:
- Hirsutism, acne
- Deepened voice
- Clitoromegaly
- Menstrual irregularities/amenorrhea (if premenopausal)
High-yield Sertoli-Leydig facts
- Usually in younger women
- Can be associated with DICER1 mutations (not always tested, but increasingly relevant)
Rapid Pattern Recognition: Ovarian Tumors by Category
Big Picture Table (high yield)
| Category | Most common examples | Typical age | Key clue(s) | Tumor markers |
|---|---|---|---|---|
| Surface epithelial | High-grade serous, mucinous, endometrioid, Brenner | Older (postmenopausal) | Ascites, peritoneal spread, papillary projections | CA-125 (esp serous) |
| Germ cell | Teratoma, dysgerminoma, yolk sac tumor, choriocarcinoma | Younger | Rapidly enlarging mass; torsion (teratoma) | LDH (dysgerminoma), AFP (yolk sac), β-hCG (choriocarcinoma) |
| Sex cord-stromal | Granulosa, thecoma, Sertoli-Leydig | Variable | Hormone effects: estrogen (granulosa/thecoma) or androgen (Sertoli-Leydig) | Inhibin (granulosa) |
“Why Every Answer Choice Matters”: What the Test Writer Is Really Testing
1) They want you to classify the tumor before you name it
Use a 3-question framework:
- Age (young = germ cell; older = epithelial; variable = sex cord)
- Hormone effects (estrogen/androgen = sex cord)
- Spread pattern + imaging (papillary + ascites = epithelial)
2) They want you to separate markers from screening
- CA-125 is not a screening test in the general population.
- It’s useful for:
- Supporting suspicion in the right context (esp postmenopausal mass)
- Monitoring response/recurrence after treatment
3) They want you to recognize that ovarian cancer is often a “GI complaint”
Bloating, early satiety, vague abdominal discomfort → think ovarian malignancy in older women, especially with ascites.
Extra High-Yield Pearls (Step 1 + Step 2)
Surface epithelial (esp high-grade serous)
- Most common ovarian malignancy
- Often bilateral, aggressive, late presentation
- Associated with BRCA1/BRCA2 (and Lynch for endometrioid/clear cell patterns)
- Can spread transcoelomically → omentum/peritoneum
Germ cell tumor marker triad (memorize)
- Dysgerminoma → LDH
- Yolk sac (endodermal sinus tumor) → AFP, Schiller-Duval bodies
- Choriocarcinoma (ovarian, nongestational) → β-hCG, early hematogenous spread
Sex cord hormone “tell”
- Granulosa/thecoma → estrogen → endometrial hyperplasia/bleeding
- Sertoli-Leydig → androgen → virilization
Takeaway: How to Nail These in 10 Seconds
If the vignette is postmenopausal + complex/papillary ovarian mass + ascites + CA-125, default to surface epithelial ovarian carcinoma, especially high-grade serous carcinoma—unless there’s a strong hormone clue pointing you toward sex cord-stromal.